Deep, qualified next-technology sequencing has disclosed that subclonal mutations (i.e., Those people current in just a portion of tumor cells) can be detected for all driver genes and therefore are affiliated with speedy disorder development and poor end result.11–13 This is especially suitable for TP53Kami bekerjasama dengan beberapa pilihan su